{"id":"W4387837059","doi":"10.1016/j.annonc.2023.09.1133","title":"1903P Tumor response by baseline metastases in patients (pts) with renal cell carcinoma (RCC) treated with lenvatinib (L) plus pembrolizumab (P) vs sunitinib (S): Post hoc analysis of the CLEAR trial","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"Eisai Incorporated; Merck Sharp and Dohme","keywords":"Medicine; Lenvatinib; Sunitinib; Pembrolizumab; Renal cell carcinoma; Oncology; Post-hoc analysis; Internal medicine; Urology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002634177,0.001035512,0.002818879,0.0002374994,0.0002544813,0.00105607,0.0007496811,0.0008381024,0.003930564],"category_scores_gemma":[0.002329432,0.000422662,0.003423421,0.0003253496,0.0007539892,0.001300699,0.0005863659,0.003057106,0.0004886294],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000778609,"about_ca_system_score_gemma":0.0009426636,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001123086,"about_ca_topic_score_gemma":0.002407284,"domain_scores_codex":[0.9985552,0.0009599114,0.00006427155,0.000195483,0.0000678637,0.0001572587],"domain_scores_gemma":[0.9984614,0.0007595049,0.000285035,0.0001318658,0.00005817622,0.0003040429],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.9793123,0.001245991,0.005232593,0.0002156338,0.003376045,0.00004368396,0.00004965895,0.000735752,0.002005265,0.00006673783,0.0007517209,0.006964562],"study_design_scores_gemma":[0.5241404,0.3631381,0.09119573,0.00007721363,0.009478386,0.000301854,0.000288918,0.004984488,0.002720352,0.0006612413,0.002914961,0.00009834945],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968535,0.001296241,0.000130129,0.0002151758,0.000102982,0.000134561,0.0006636591,0.00002080854,0.0005828735],"genre_scores_gemma":[0.9975014,0.0003762628,0.0001805466,0.000155601,0.000116153,0.000150013,0.0007214723,0.00001262899,0.0007857996],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003930564,"threshold_uncertainty_score":0.01393104,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04502607185774601,"score_gpt":0.310730958205629,"score_spread":0.2657048863478829,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}